ARCHIVES

Doxil/Caelyx Survival 3 Weeks Longer Than Topotecan

This article is from The Cancer Letter archive.

Vol. 26 No. 11 | November 28, 2003

Download PDF Visit The Full Archive

Related Articles

Screening Mammograms In Young Women Have Low Accuracy, Detect Few Cancers

May 28, 2010

NCA Asks HHS To Exempt From DRG Peer Reviewed Institutions With At Least 25 Protocol Patients

August 12, 1983

First CCOP 3 Returns In; Payline Not Yet Determined; Goes to NCAB On Jan. 30

January 26, 1990

Cancer Policy Board urges distinct care for cancer survivors.

November 11, 2005

PDQ Evaluation to Cost NCI More Than Reported

June 29, 1990

AIDS Cachexia Drug Stabilizes Body Weight, Muscle Mass

March 29, 2013